It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
“We are working to locate the individual and get him to a comfortable, compassionate place where we can monitor him and care for his every need for the full incubation period,”d,” Jenkins said in an emailed statement. “I want to emphasize that he is a low risk individual and we are doing this out of precautionary measures.”
originally posted by: antar
a reply to: marg6043
Right, my extreme relatives are on as usual, they have no doubt that this will not affect good Christians, this is God punishing the blacks. I could go into this and the conversations I have had but will not waste the bandwidth to do so. Its unbelievable that they think the Lord will protect.
originally posted by: DancedWithWolves
Update on Kansas City quarantine involving a Nigerian woman with Ebola-like symptoms.
Kansas City TV station, KCTV-5 reported Saturday night someone was being quarantined at Rockhill Research Hospital (Research Medical Center), according to their sister station in Wichita, KWCH.
A source in Kansas City confirmed the story to the Gateway Pundit and added some details.
A Nigerian woman was taken to the hospital with a high fever and Ebola like symptoms. Her apartment building was quarantined, though that may have been lifted later.
The source added the Nigerian woman initially tested negative for Ebola and was released (or set to be released) but was called back to the hospital. The source said parts of the hospital may be quarantined but the hospital is not confirming anything.
The CDC is reportedly on the way, according to the source.
originally posted by: antar
a reply to: netwarrior
Are you thinking that Z. strain is less dangerous? No Z is the most dangerous. The Marlburg (sp) is the least and it causes among other things implosive testicles and eyes...
LONDON – Scientists have used Ebola disease spread patterns and airline traffic data to predict a 75 percent chance the virus could be imported to France by 24 October, and a 50 percent chance it could hit Britain by that date.
The scientist who discovered the Ebola virus said that a current outbreak of the deadly bug in West Africa, in which 467 people have died, is “unprecedented.”
“One, [this is] the first time in West Africa that we have such an outbreak,” Dr. Peter Piot told CNN’s Christiane Amanpour. “Secondly, it is the first time that three countries are involved. And thirdly it’s the first time that we have outbreaks in capitals, in capital cities.”
Doctors Without Borders warns that the outbreak in Guinea, Sierra Leone, and Liberia is now “out of control.” The number of cases is still spiking since it was first observed around the beginning of this year.
“With this strain of Ebola, you’ve got like a ninety percent chance of dying. That’s spectacular by any standard – one of the most lethal viruses that exist.”
And the way victims die is far from pleasant.
All agreed on the ultimate goal: to have a fully tested and licensed product that can be scaled up for use in mass vaccination campaigns.
Two promising candidate vaccines
Given the public health need for safe and effective Ebola interventions, WHO regards the expedited evaluation of all Ebola vaccines with clinical grade material as a high priority.
Two candidate vaccines have clinical-grade vials available for phase 1 pre-licensure clinical trials.
One (cAd3-ZEBOV) has been developed by GlaxoSmithKline in collaboration with the US National Institute of Allergy and Infectious Diseases. It uses a chimpanzee-derived adenovirus vector with an Ebola virus gene inserted.
The second (rVSV-ZEBOV) was developed by the Public Health Agency of Canada in Winnipeg. The license for commercialization of the Canadian vaccine is held by an American company, the NewLink Genetics company, located in Ames, Iowa. The vaccine uses an attenuated or weakened vesicular stomatitis virus, a pathogen found in livestock; one of its genes has been replaced by an Ebola virus gene.